Members | Market | Warrants | Research | A.I. | Education | AASTOCKS | Products | US Stocks
Back to Home  
Member Service| Live Picks| Top Features| Back Test| Market| Tech Analysis| University| About Tradetrek
Block Trades | Money Flow | VWAP | Fundamentals | Historical chart walker | Back Test | Stock Code Lookup
Stock ID: Quote Chart News Fundamentals Comment 5-day Forecast 6-month Target
 
Jun 19, 2025   06:18:54 a.m.
Print  Forward
2002-8-14   07:55:00 a.m. HKT, XFNA
Everpride Biopharmaceutical H1 net loss 9.503 mln yuan vs profit 17.101 mln
 


HONG KONG (AFX-ASIA) - Everpride Biopharmaceutical Co Ltd (8019.HK) six months to June results:

Sales - 22.982 mln yuan vs 73.183 mln

Opg loss - 9.324 mln yuan vs profit 21.65 mln

Net loss - 9.503 mln yuan vs profit 17.101 mln

Loss per share - 1.58 fen vs EPS 3.72 fen

Interim div - nil, unchanged

rachel.arputharajoo@afxnews.com

ra/jv





AFN
 

News Provided by XFNA
 
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved
 
 

Disclaimers | Privacy Policy | Career Opportunities | Contact Us | Help
www.aastocks.com
Support Hotline:(852)2186 8685/ (852) 2121 8803
Email: support@aastocks.com
Copyright 2000 AASTOCKS.com Ltd. All rights reserved.
AASTOCKS.com LIMITED is a SFC registered Investment Advisor.
Note: AASTOCKS.com Ltd endeavors to ensure the accuracy and reliability of the information provided but does not guarantee its accuracy or reliability and accepts no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.